InspireMD

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard™ Prime Carotid Stent System We’re thrilled to announce the establishment of our new global headquarters in Miami, Florida. This pivotal move positions InspireMD to support the highly anticipated U.S. launch and commercialization of the CGuard™ Prime Carotid Stent System, targeting FDA approval in the first half of 2025. As we build a world-class commercial and operational team, our new U.S.-based headquarters will drive long-term growth, support innovation, and provide exceptional service to the U.S. market. 🏢 Why South Florida? This region is a hub of medical device innovation, providing access to top-tier talent and resources crucial to our mission. For full details, read the official press release here: https://lnkd.in/drBRsBck Stay tuned for more updates as we prepare for an exciting journey ahead! #StrokePrevention #Innovation #CarotidStenting #Carotid #CGuardPrime #CGuard #Healthcare #USLaunch

In case you missed the recent ICCA Stroke webinar on the Comeback of Carotid Stenting - Don't worry, we've got you covered! 🎥 For the latest advancements in carotid intervention, dive right into this must-watch webinar recording: https://lnkd.in/eg8gPewQ Many thanks to the ICCA Stroke organizers and the esteemed panel of Prof. Dr. med. Iris Grunwald, Professor Klaus Mathias, Adnan Siddiqui, MD, PhD, Horst Sievert and Musiałek Piotr for their contribution and insightful discussion. #cas #carotid #tcar #cguard #strokeprevention #cguard #carotidstenting #ICCAvirtual ICCA Stroke

🚨InspireMD Announces FDA Approval of IDE Application for CGUARDIANS II Pivotal Study We are thrilled to announce that the U.S. FDA has approved InspireMD’s Investigational Device Exemption (IDE) application to initiate the CGUARDIANS II pivotal study of our CGuard Prime 80cm Carotid Stent System for transcarotid revascularization (TCAR) procedures. Our CEO, Marvin Slosman stated, “The approval of our CGUARDIANS II IDE is an important milestone and a significant step forward in our mission to serve the broadest range of physician and patient needs with a comprehensive set of tools that can deliver our best-in-class carotid stent system, CGuard Prime, for both CAS and TCAR procedures.” We are honored to have Dr. Patrick Geraghty and Dr. Patrick Muck as co-principal investigators leading this trial, alongside a world-class group of investigators committed to the trial’s success. This study is a key component of our ongoing efforts to bring stroke prevention innovation to the U.S. market and support our mission to enhance patient care and stroke-free outcomes. For the press release and full details, click below: #StrokePrevention #CarotidStent #CGuard #Carotid #CGUARDIANS #TCAR #Innovation #MedicalAdvancements

Concluding a valuable week at #ESVS2024 in Kraków! It was an enriching experience filled with inspired discussions and knowledge sharing. We are very pleased with the insightful Carotid Pathway session on Thursday afternoon and Dr. José Ignacio Leal Lorenzo’s valuable talk on the clinical advantages of new stent designs. Big thanks to the organizers, attendees, and everyone who visited us at Booth #27. Together, we’re making remarkable progress in advancing vascular health. #CarotidInnovation #VascularHealth #StrokePrevention #Carotid #MedicalInnovation

Good times at #ESVS2024 in Kraków, Poland!  We're thrilled to be part of this valuable congress, exchanging knowledge and driving forward innovation in vascular health. Many thanks to our enthusiastic participants in the "Carotid Pathway" workshop with #CGuard flow model training and Kudos to Muli Vered for representing us in the ESVS Charity Run! Tomorrow, don’t miss the ESVS symposium: "Surgery, Stenting, or Medical Treatment? The Evidence, the Argument, and the Trials We Need" at THEATRE HALL from 11:30 to 12:25 where Dr. José Ignacio Leal Lorenzo will discuss "We Need to Include New Stent Designs – They Deliver Better Results."   Be sure to visit us at Booth #27 and connect with our team! ESVS Society #CarotidInnovation #VascularHealth #StrokePrevention #Carotid #MedicalInnovation #Networking #HealthcareTransformation

Join us for "The Comeback of Carotid Stenting" webinar this coming Wednesday, on September 25th from 18:00 to 20:00 CEST. Explore the latest advancements in carotid artery stenting, featuring top experts: 🧠 How we put carotid artery stenting back on stage in the US Adnan Siddiqui, MD, PhD, Neurosurgeon, USA – The success story of the Multi-Specialty Carotid Alliance. 🛡️ Proximal protection for all carotid stent cases Prof. Dr. Horst Sievert, Interventional Angiologist & Cardiologist, Germany. 🔬 Micromesh carotid stents – a major step forward Musiałek Piotr, Interventional Cardiologist, Poland. Don't miss this opportunity to learn about the future of carotid artery stenting from the best experts in the field! Register now>>> https://lnkd.in/gnwqH943 ICCA Stroke #CarotidInnovation #VascularHealth #Strokeprevention #Carotid #MedicalInnovation

🚨 Exciting Milestone! InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System This submission is based on outstanding results from our pivotal C-GUARDIANS trial, showcasing a major adverse event rate of just 1.95%—the lowest of its kind for any carotid stent or embolic protection device pivotal trial to date. Marvin Slosman, chief executive officer of InspireMD, stated, “... We look forward to the agency’s review of our application, which we have provided in a modular submission to facilitate the most efficient review process. Concurrently, we continue to build what I consider to be world class U.S. commercial and operational infrastructure to enter the U.S. market with as much momentum as possible to offer to this breakthrough technology.”  #StrokePrevention #MedicalInnovation #FDA #CarotidStent #Carotid #InspireMD #CGuardPrime #HealthcareInnovation #ClinicalTrials For the complete announcement click below:

Join Us at #ESVS2024 in Krakow, Poland!  🗓 September 24-27 📍 Booth #27 We are excited to invite you to meet up with the InspireMD professional team at #ESVS. We look forward to sharing with you the advancements we are bringing to vascular health and share with you the best-in-class clinical data with #CGuard EPS for stroke prevention in carotid artery stenting. Join us for the Carotid Pathway workshop, for hands-on training and a deep dive into the CAS technologies that are shaping the future of carotid intervention >>> https://lnkd.in/d9Nuz6Gn See you there! 👋 ESVS Society #ESVS2024 #CarotidInnovation #VascularHealth #Strokeprevention #Carotid #MedicalInnovation #Networking

Great experience at #ESMINT2024!  A big thank you to all the leading physicians and colleagues in the neurointerventional community who stopped by our booth to learn about #CGuard EPS for stroke prevention and stayed for insightful conversations on how to improve patient care. It was a pleasure, as always, to spend these days with our dedicated professional team! 👏 Stay tuned for more updates, and we look forward to seeing you next year at #ESMINT2025! #Strokeprevention #Carotid #MedicalInnovation #Networking #ESMINT2024 #Neurointervention #Innovation

Live from #ESMINT2024! 🌟 First Day of ESMINT comes to an end!  It was a pleasure engaging in valuable conversations with the leading physicians and colleagues in the neurointerventional community. We look forward to the days ahead and invite you to stop by our booth #21 to hear all about #CGuard EPS for stroke prevention at #ESMINT2024 and say Salut! #StrokeCare #Carotid #MedicalInnovation #Networking #ESMINT2024 #Neurointervention #Innovation